Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1750
| Despition | LCN1 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1271 | Alpha Synuclein Blocking Peptide (AC1271) | 250 µg | inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
| ACPP-1444 | Human VAMP2 Protein (AC1444) | 5 µg | inquiry |
| ACPP-1103 | Rat Leptin Protein (AC1103) | 200 µg | inquiry |
| ACPP-1664 | Human BLMH Protein (AC1664) | 5 µg | inquiry |
| ACPP-1463 | Human BCL2L11 Protein (AC1463) | 2 µg | inquiry |
| ACPP-1320 | FGFR4 Blocking Peptide (AC1320) | 250 µg | inquiry |
| ACPP-1151 | Recombinant HuD Protein (AC1151) | 10 µg | inquiry |
| ACPP-1608 | Human INHBC Protein (AC1608) | 2 µg | inquiry |
| ACPP-1348 | Presenilin 1 Blocking Peptide (AC1348) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.